CRISPR/Cas9 screening reveals Zfp607b as a novel transcription factor regulating myogenesis
CRISPR/Cas9 screening reveals Zfp607b as a novel transcription factor regulating myogenesis Skeletal muscle formation (myogenesis) is a complex process, and transcription factors (TFs) play an important role in controlling the phases of developmental myogenesis, particularly in myoblast proliferation and differentiation. 1 However, the functions of numerous TFs in myoblast development and myogenesis remain unclear.To systematically identify TFs regulating myogenesis in skeletal muscle, we performed a genome-scale CRISPR-Cas9 loss-offunction (LOF) screen in mouse myoblast cells to identify TFs whose loss contributes to skeletal muscle proliferation.After screening, we identified 855 TFs closely associated with C2C12 cell proliferation.Functionally, we validated that Zfp607b improved skeletal muscle differentiation and regeneration using RNA interference knockdown in vitro and lentiviral injection in vivo.For the top fold-change genes in the TF knockout cell library, we explored potential mechanisms using transcriptomics and immunofluorescence.In conclusion, we constructed a genome-wide TF knockout cell library in myoblast and identified a novel TF, Zfp607b, that significantly participated in myogenesis and skeletal muscle regeneration.Our findings contribute to the understanding of the ZFP family involved in myogenesis and regeneration and provide a platform for studying the biological function of TFs in the future.Furthermore, our study offers valuable resources for understanding skeletal muscle development and human muscle-related diseases.In this study, we successfully established a monoclonal C2C12-Cas9 cell line and identified the CRISPR efficiency using Western blot, indirect immunofluorescence assay, and gene editing sequencing.Cas9 proteins were detected via Western blot (Fig. S1A), and the results of indirect immunofluorescence assay showed Cas9 proteins expressed in the cytoplasm of C2C12-Cas9 monoclonal cells, indicated by
Authors
- Chao Yan (ORCID: https://orcid.org/0000-0003-0527-5719)
- Shengsong Xie (ORCID: https://orcid.org/0000-0002-8301-877X)
- Wangchang Li (ORCID: https://orcid.org/0000-0003-1965-8024)
- Zishuai Wang (ORCID: https://orcid.org/0000-0002-4496-8430)
- Zhonglin Tang (ORCID: https://orcid.org/0000-0002-4538-4349)
- Weiwei Liu (ORCID: https://orcid.org/0000-0001-6997-2412)
- Siyuan Liu (ORCID: https://orcid.org/0000-0002-0571-2045)
- Guohao Han (ORCID: https://orcid.org/0000-0001-8648-7347)
- Yuxing Huang (ORCID: https://orcid.org/0000-0002-1697-987X)
- Wei J. Wang (ORCID: https://orcid.org/0000-0002-4848-7394)
Institutions
- Huazhong Agricultural University (CN)
- Agricultural Genomics Institute at Shenzhen (CN)
- Ministry of Agriculture (CA)
- Chinese Academy of Agricultural Sciences (CN)
- Shenzhen Third People’s Hospital (CN)
Publication Details
- Journal
- Genes & Diseases
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1016/j.gendis.2024.101444
- Citations
- 1
- Primary Topic
- Muscle Physiology and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- National Natural Science Foundation of China
- Chinese Academy of Agricultural Sciences
- Agricultural Science and Technology Innovation Program